RxDoctor Payments Data

Brian Cone

Anatomic Pathology & Clinical Pathology · Los Angeles, CANPI 1568856532

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $516,665 of the $518,631 with a category attached, or 99.6%. Roche Molecular Systems, Inc. accounts for 99.7% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $192,970, more than ten times the $21 reported in 2019. Among anatomic pathology & clinical pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$518,631in general payments, 2019–2025

Across 40 payments — averaging $12,966 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Molecular Systems, Inc.$517K
  • Agilent Technologies, Inc.$2K
  • Leica Microsystems Inc.$21
  • Merck$20

What the payments were for

  • Consulting fees$1,5650%
  • Speaking & faculty fees$516,665100%
  • Travel & lodging$3600%
  • Food & beverage$410%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$518,631 in reported general payments places this provider in the 95th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California

Other anatomic pathology & clinical pathology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →